NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/29/2025
Back to search
Official data from USPTO
OCTAPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/30/2025
Trademark type
Combined
Nice classes
5, 40, 44
Filing date
07/14/2017
Registration date
07/17/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Lachen, CH
Examiner
CLAYTON, CHERYL
Current location
Historical data usage
Mark description
The mark consists of the word "otapharma".
Holders and representatives
Holders
Octapharma AG
Representatives
Henry B. Ward, III Bradley Arant Boult Cummings LLP
Technical classification
Nice Classes
Class 5Class 40Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsparticularly blood plasma preparationsplasma derivativescoagulation factorsgrowth factorsproteins derived from plasma
Class 40
Treatment of materialstreatment of blood or blood plasma in pharmaceutical preparationsparticularly of blood plasma preparationsplasma derivativescoagulation factorsgrowth factorsproteins derived from plasma
Class 44
Medical servicesparticularly the medical services of a blood donation center
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/29/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/29/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/13/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/06/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/17/2018
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/11/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/11/2018
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/04/2018
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/04/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2017
DOCK
ASSIGNED TO EXAMINER
08/25/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2017
NWAP
NEW APPLICATION ENTERED
07/18/2017
Continuous trademark protection
Get notified about every new filing that threatens OCTAPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.